RxDoctor Payments Data

Donald Vogel, MD

Family Medicine · Sylvania, OHNPI 1437151297

Payments from drug & device makers

$361in general payments, 2019–2025

Across 20 payments — averaging $18.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$116
  • Novo Nordisk$62
  • GSK$34
  • Vanda Pharmaceuticals Inc.$30
  • Boehringer Ingelheim$23
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$19
  • plus $77 from 5 others

What the payments were for

  • Food & beverage$32991%
  • Education$329%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$361 in reported general payments places this provider in the 45th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$122,533
Medicare patients
278
Services billed
1,585

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban88$89,277
OzempicSemaglutide35$40,753
XareltoRivaroxaban32$24,880
MounjaroTirzepatide22$21,408
JanuviaSitagliptin Phosphate20$16,339
JardianceEmpagliflozin15$15,760
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$14,871
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog22$10,232
FarxigaDapagliflozin Propanediol15$9,399
Lantus SolostarInsulin Glargine,hum.Rec.Anlog49$6,334
Metoprolol Succinate313$5,593
Levothyroxine Sodium554$5,455
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,332
Tamsulosin Hcl179$5,117
Albuterol Sulfate HfaAlbuterol Sulfate142$4,590

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$62$40,75335 claims
Lilly USA, LLCMounjaro$15$21,40822 claims
GSKTrelegy Ellipta, Anoro Ellipta$34$20,20330 claims
Boehringer IngelheimJardiance$23$15,76015 claims
AstraZenecaFarxiga$16$9,39915 claims
AbbVieSynthroid$116$2,20354 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Sylvania

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →